Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Arcturus Therapeutics Inc patents


Recent patent applications related to Arcturus Therapeutics Inc. Arcturus Therapeutics Inc is listed as an Agent/Assignee. Note: Arcturus Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Arcturus Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Arcturus Therapeutics Inc-related inventors


Ionizable cationic lipid for rna delivery

R4 and R5 are the same or different, each a linear or branched alkyl with 1 to 6 carbons.... Arcturus Therapeutics Inc

Aromatic ionizable cationic lipid

or a pharmaceutically acceptable salt thereof.... Arcturus Therapeutics Inc

Lipid particles with cationic lipids for rna delivery

or a pharmaceutical preparation thereof.... Arcturus Therapeutics Inc

Ionizable cationic lipid for rna delivery

or a pharmaceutically acceptable salt thereof.... Arcturus Therapeutics Inc

Molecules and agents for treating hepatitis b virus

This invention encompasses compounds and compositions useful in methods for medical therapy, in general, for inhibiting Hepatitis B virus in a subject. The compounds have a first strand and a second strand, each of the strands being 19-29 monomers in length, the monomers comprising UNA monomers and nucleic acid monomers,... Arcturus Therapeutics Inc

Ionizable cationic lipid for rna delivery

or a pharmaceutically acceptable salt thereof.... Arcturus Therapeutics Inc

Ionizable cationic lipid for rna delivery

or a salt, a solvate, or a pharmaceutical formulation thereof.... Arcturus Therapeutics Inc

Allele selective gene editing and uses thereof

This invention encompasses compounds, structures, compositions and methods for therapeutic guide molecules that direct CRISPR gene editing. A guide molecule for directing gene editing can be allele selective, or disease allele selective, and can exhibit reduced off target activity. A guide molecule can be composed of monomers, including UNA monomers,... Arcturus Therapeutics Inc

Multiligand agent for drug delivery

wherein R comprises a double stranded RNA molecule, and L1, L2, and L3 independently for each occurrence comprise a ligand selected from the group consisting of a carbohydrate, a cholesteryl, or a peptide; a pharmaceutically accepted salt or pharmaceutical composition thereof; and a method of making the compound.... Arcturus Therapeutics Inc

Compositions and agents against hepatitis b virus and uses thereof

This invention encompasses compounds and compositions useful in methods for medical therapy, in general, for inhibiting Hepatitis B virus in a subject. The compounds have a first strand and a second strand, each of the strands being 19-29 monomers in length, the monomers comprising UNA monomers and nucleic acid monomers,... Arcturus Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Arcturus Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arcturus Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###